NOA-09/CeTeG-Trial (randomized phase 3 study of combined CCNU/temozolomide therapy versus standard temozolomide therapy in first-line therapy of patients with newly diagnosed MGMT-methylated glioblastoma)
NOA-08-Trial (Temozolomide - one week on/one week off - versus radiotherapy in first-line therapy of anaplastic astrocytomas and glioblastomas in older patients)
